CA-ESRI
27.1.2021 17:02:08 CET | Business Wire | Press release
Esri , the global leader in location intelligence, today announced the launch of ArcGIS Platform, a geospatial platform as a service (PaaS) for developers that need to integrate location capabilities into their apps, business systems, and products. ArcGIS Platform gives developers direct access to Esri's powerful location services using the APIs and web frameworks of their choice.
"ArcGIS Platform lets users build their own products or integrate Esri services into existing software," said Jack Dangermond, Esri founder and president. "This PaaS makes it easier for software developers to access geospatial technology."
"With the release of ArcGIS Platform, developers now have access to professional-grade content and capabilities they can readily plug into their apps, allowing them to stay on budget while delivering enormous value by reducing time to market," said David Cardella, Esri product manager for developer technologies.
Scaling with developers and their apps, ArcGIS Platform lets customers leverage the same framework and services whether they're supporting dozens of users or millions of them.
"We're excited our partnership with Esri has continued with the integration of ArcGIS Platform," said Ben Brantly, VP of product at Salesforce. "Esri's collection of ready-to-use basemaps gives our users a solution to better understand their data by presenting it visually on a map. The capabilities of ArcGIS Platform allow us to continue to expand the value we provide to Salesforce Maps users by leveraging additional Esri location services as well as the adoption of the ArcGIS API for JavaScript."
Esri is unveiling ArcGIS Platform at a virtual event today, where users like Salesforce and cloud-based drone management capability provider Airspace Link are speaking about how they use Esri's PaaS technology.
"Fused with local data, Esri's demographic and geocoding services help us deliver a product that promotes safe, compliant drone operations for our customers across the country," said Airspace Link Cofounder, President, and CEO Michael Healander.
Longtime Esri partner, SAP, is also featured in the launch event. “Location services from Esri’s ArcGIS Platform will be exposed through SAP’s cloud consumption model, which plays to the strength of what customers are looking for,” said Irfan Khan, President for Platform &Technology at SAP. “SAP’s Business Technology Platform provides an ideal integration point, allowing developers to more easily build innovative applications that combine real-time business data with geospatial intelligence.”
To learn more about Esri, a leader in The Forrester Wave™: Location Intelligence Platforms, Q2 2020, and ArcGIS Platform and how it delivers low-cost, high-quality location services to developers, visit go.esri.com/Platform-Learn-More .
About Esri
Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com .
Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.
Additional Quotes
“Esri’s location services integrate easily with Autodesk – together we’re changing the way the industry works.”
Theo Angelopoulos, Senior Director, Infrastructure Business Strategy & marketing, Autodesk
“With the launch of Esri’s new location platform, we look forward to accessing a greater number of services with more flexibility to make our offerings even more meaningful.”
George Mastakas, VP Enterprise Solutions and Corporate Partnerships, CityWorks
“Reliable, scalable location services from Esri allow us to focus on delivering innovative solutions.”
Brian J. Smith, Senior Vice President, GeoDecisions – A Division of Gannett-Fleming, Inc.
“The flexibility, increased speed, and variety of mapping and imagery layers gives our users unprecedented control over their risk assessments.”
John Goolgasian, Chief Operating Officer, Geospark Analytics
“We rely on Esri location services to provide scalable, tailored solutions for our customers.”
Steve Mulberry, Geospatial Innovation Strategist, GISinc
“With the seemingly endless capabilities provided by Esri location services, K&A can quickly and effectively integrate location intelligence into our solutions and our clients’ business workflows for an improved customer experience.”
Walid Abou Chacra, Manager, Electricity Segment, Khatib & Alami
“We highly recommend Esri location services as the premier technology to help utilities optimize their network for the future.”
Chris Erpelding, GIS Consulting Department Manager, POWER Engineers
“Esri location services enables Schneider Electric to build world class solutions that manage the lifecycle of the Utility Network.”
Jay Stinson, Vice President, Digital Grid Asset Management Business, Schneider Electric
“The newest ArcGIS Platform architecture enables us to provide solutions embedding advanced spatial capabilities to our customers faster and easier than ever before.”
Signe Bramming Andersen, Director of Business Development, Similix
“Esri location services provide flexibility in our programs and products, and expands the value of GIS for our customers.”
Adam Tonkin, CTO, SSP Innovations
“Esri’s location services are a crucial component of Cartegraph’s mission to optimize the productive life of every infrastructure asset – indoors, outdoors, above and below ground.”
Josh Mallamud, CEO, Cartegraph
“When our customers need to provision high-precision apps for offline field work with Geocortex Mobile, or publish modern mapping apps with all the tools tailored for their staff’s needs, they rely on Geocortex and ArcGIS Platform to take those apps to the next level.”
Jon Brooks, CEO, VertiGIS
View source version on businesswire.com: https://www.businesswire.com/news/home/20210127005050/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom